Therapeutics | News | 0 Comment | 26 Oct, 2024
The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform orig...Read more
HELP Therapeutics Secures FDA Approval for Phase I Study of HiCM-188 in Heart Failure Treatment
Therapeutics | News | 0 Comment | 22 Oct, 2024
HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...Read more
Therapeutics | News | 0 Comment | 18 Oct, 2024
Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of researc...Read more
Singapore discovers novel gene therapy offering hope for epilepsy patients
Therapeutics | News | 0 Comment | 15 Oct, 2024
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) are working on a t...Read more
Therapeutics | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 14 Oct, 2024
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...Read more
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding
Therapeutics | News | 0 Comment | 13 Oct, 2024
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...Read more
National University of Singapore and Imperial College London establish major research partnership
Therapeutics | News | 0 Comment | 13 Oct, 2024
National University of Singapore (NUS) and Imperial College London have announced a new partnership to strengthen resear...Read more
Therapeutics | News | 0 Comment | 11 Oct, 2024
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...Read more
$18 M investment for world-first Australian research project for heart attack protection
Therapeutics | News | 0 Comment | 07 Oct, 2024
The government is investing almost $18 million in a world-first Australian research project that will trial a drug disco...Read more
Singapore strategises advance modalities for cancer- and age-related muscle degeneration
Therapeutics | News | 0 Comment | 26 Sep, 2024
The global population is aging rapidly, and sarcopenia, a condition that severely diminishes quality of life in older ad...Read more
Bio-Sourcing secures EIC Accelerator funding to enhance biomanufacturing
Therapeutics | News | 0 Comment | 24 Sep, 2024
Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces the award of €2.5M in grants and €10M in ...Read more
Therapeutics | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 01 Sep, 2024
Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...Read more
Australia designs world first wearable device to record impact of artificial light for sound sleep
Therapeutics | News | 0 Comment | 25 Aug, 2024
In a world first, a new wearable device developed by Australia's Monash University researchers will help to record the i...Read more
Singapore approves GSK's Jemperli plus chemotherapy as first frontline immuno-oncology treatment
Therapeutics | News | 0 Comment | 08 Aug, 2024
GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperl...Read more
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute's MyoAAV Plasmids
Therapeutics | News | 0 Comment | 07 Aug, 2024
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...Read more
Abu Dhabi announces first gene transfer therapy for duchenne muscular dystrophy
Therapeutics | News | 0 Comment | 06 Aug, 2024
Department of Health – Abu Dhabi (DoH) has provided revolutionary gene transfer therapy for Duchenne muscular dyst...Read more
Boston Oncology to advance localised cell and gene therapies in Saudi Arabia
Therapeutics | News | 0 Comment | 02 Aug, 2024
Under an important initiative aimed at transforming healthcare in the Kingdom of Saudi Arabia, Boston Oncology and King ...Read more
Singapore MOH includes Roche’s spinal muscular atrophy (SMA) drug in MAF framework
Therapeutics | News | 0 Comment | 01 Aug, 2024
EVRYSDI® (risdiplam) has been added to the Singapore Ministry of Health’s (MOH) list of medicines covered...Read more